Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1766827

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1766827

United States Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

PUBLISHED:
PAGES: 416 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "United States Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The United States Oncology Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the United States Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Oncology is segmented as follows -

  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests

Reasons to Buy

The United States Oncology Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25630CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Oncology Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Oncology Market, United States

  • 3.1 Oncology Market, United States, Revenue ($m), 2018-2033
    • 3.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.2 BCR-ABL Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.3 BRAF Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.4 BRCA Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.5 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.6 EGFR Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.7 HER2 Tests Market, United States, Revenue ($m), by Segment, 2018-2033
    • 3.1.8 KRAS Tests Market, United States, Revenue ($m), by Segment, 2018-2033
  • 3.2 Oncology Market, United States, Volume (Units), 2018-2033
    • 3.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.2 BCR-ABL Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.3 BRAF Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.4 BRCA Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.5 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.6 EGFR Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.7 HER2 Tests Market, United States, Volume (Units), by Segment, 2018-2033
    • 3.2.8 KRAS Tests Market, United States, Volume (Units), by Segment, 2018-2033
  • 3.3 Oncology Market, United States, Average Price ($) , 2018-2033
  • 3.4 Oncology Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Oncology Market

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

7 Recent Developments

8 Appendix

Product Code: GDME25630CCDB

List of Table

List of Tables

  • Table 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 10: Oncology Market, United States, Volume (Units), 2018-2033
  • Table 11: ALK Tests Market, United States, Volume (Units), 2018-2033
  • Table 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
  • Table 13: BRAF Tests Market, United States, Volume (Units), 2018-2033
  • Table 14: BRCA Tests Market, United States, Volume (Units), 2018-2033
  • Table 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
  • Table 16: EGFR Tests Market, United States, Volume (Units), 2018-2033
  • Table 17: HER2 Tests Market, United States, Volume (Units), 2018-2033
  • Table 18: KRAS Tests Market, United States, Volume (Units), 2018-2033
  • Table 19: Oncology Market, United States, Average Price ($), 2018-2033
  • Table 20: Oncology Market, United States, Company Share by Revenue ($m), 2024
  • Table 21: Oncology Market Pipeline Products
  • Table 22: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
  • Table 23: Hanmi Pharma and LG Invests USD5 Million in MEDiC Life Sciences
  • Table 24: Starboard Value May Acquire Stake in Pfizer for USD1 Billion
  • Table 25: VION Biosciences Acquires Ansh Labs
  • Table 26: DERM-JES Holdings Acquires DermTech
  • Table 27: Breath Diagnostics Raises USD1 Million in Private Placement of Convertible Notes
  • Table 28: Kiyatec Raises USD0.25 Million in Debt Offering
  • Table 29: Laboratory Corp of America Holdings Raises USD650 Million in Public Offering of 4.35% Notes Due 2030
  • Table 30: Laboratory Corp of America Holdings Raised Public Offering of 4.55% Notes Due 2032 for USD500 Million
  • Table 31: Laboratory Corp of America Holdings Raises USD850 Million in Public Offering of 4.8% Notes Due 2034
  • Table 32: Illumina Prices USD500 Million in Public Offering of 4.65% Notes Due 2026
  • Table 33: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

  • Figure 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 10: Oncology Market, United States, Volume (Units), 2018-2033
  • Figure 11: ALK Tests Market, United States, Volume (Units), 2018-2033
  • Figure 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
  • Figure 13: BRAF Tests Market, United States, Volume (Units), 2018-2033
  • Figure 14: BRCA Tests Market, United States, Volume (Units), 2018-2033
  • Figure 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
  • Figure 16: EGFR Tests Market, United States, Volume (Units), 2018-2033
  • Figure 17: HER2 Tests Market, United States, Volume (Units), 2018-2033
  • Figure 18: KRAS Tests Market, United States, Volume (Units), 2018-2033
  • Figure 19: Oncology Market, United States, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!